This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Vaccine Strategy in Melanoma - p. 337 10. Vaccine Therapies for Breast Cancer - p. 353 11. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies - p. 369 12. Immunotherapy Toxicities - p. 387 13. Current Immunotherapy Practices in Melanoma - p. 403 14. Oncolytic Immunotherapy - p. 419 15. Immunologic Targeting of Cancer Stem Cells - p. 431 16. Immunotherapy in Ovarian Cancer - p. 447 17. Adoptive T-Cell Therapy for Solid Malignancies - p. 465 18. Role of Surgery in Combination with Immunotherapy - p. 481 19. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy - p. 489 20. Future Research Goals in Immunotherapy - p. 505
This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Vaccine Strategy in Melanoma - p. 337 10. Vaccine Therapies for Breast Cancer - p. 353 11. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies - p. 369 12. Immunotherapy Toxicities - p. 387 13. Current Immunotherapy Practices in Melanoma - p. 403 14. Oncolytic Immunotherapy - p. 419 15. Immunologic Targeting of Cancer Stem Cells - p. 431 16. Immunotherapy in Ovarian Cancer - p. 447 17. Adoptive T-Cell Therapy for Solid Malignancies - p. 465 18. Role of Surgery in Combination with Immunotherapy - p. 481 19. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy - p. 489 20. Future Research Goals in Immunotherapy - p. 505
